| P2093 | author name string | Tian-Biao Zhou | |
| P2860 | cites work | FGF-1 induces expression of LXRalpha and production of 25-hydroxycholesterol to upregulate the apoE gene in rat astrocytes | Q24312559 |
| | Structure of the Minimal Interface Between ApoE and LRP | Q27660292 |
| | Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 |
| | FGF-1-induced reactions for biogenesis of apoE-HDL are mediated by src in rat astrocytes | Q28564153 |
| | A role for LRP4 in neuronal cell viability is related to apoE-binding | Q28579075 |
| | The key role of apolipoprotein E in atherosclerosis | Q33213990 |
| | Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment | Q33938891 |
| | Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes. | Q34049704 |
| | Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice | Q34308238 |
| | Apolipoprotein E: From lipid transport to neurobiology | Q34497951 |
| | Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice | Q35089867 |
| | Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus | Q35177939 |
| | Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis | Q35788548 |
| | Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene | Q35794576 |
| | AP-2β regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytes | Q35798851 |
| | Impact of apoE genotype on oxidative stress, inflammation and disease risk | Q37059819 |
| | Regulation of endogenous apolipoprotein E secretion by macrophages | Q37128264 |
| | Functional interactions of APP with the apoE receptor family | Q37191382 |
| | Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria | Q37330532 |
| | Human immunodeficiency virus downregulates podocyte apoE expression | Q37337364 |
| | Atherosclerosis in chronic kidney disease: the role of macrophages | Q37811885 |
| | Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town | Q37870892 |
| | The podocyte cytoskeleton--key to a functioning glomerulus in health and disease | Q37949258 |
| | The potential mechanism for the different expressions of gelatinases induced by all-trans retinoic acid in different cells | Q37999846 |
| | The signaling pathways of LMX1B and its role in glomerulosclerosis | Q38050536 |
| | Signaling pathways of PAX2 and its role in renal interstitial fibrosis and glomerulosclerosis | Q38058558 |
| | Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux | Q38342755 |
| | LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL | Q38503442 |
| | Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS. | Q39672169 |
| | Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer. | Q39709153 |
| | N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein | Q39965041 |
| | Apoptosis induces neuronal apolipoprotein-E synthesis and localization in apoptotic bodies | Q40167264 |
| | Transforming growth factor-beta-induced expression of the apolipoprotein E gene requires c-Jun N-terminal kinase, p38 kinase, and casein kinase 2. | Q40294758 |
| | Induction of apolipoprotein E expression by TR4 orphan nuclear receptor via 5' proximal promoter region. | Q40465949 |
| | Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. | Q41868060 |
| | Effect of Apolipoprotein E Gene Polymorphism on Serum Lipid Level Before and After Renal Transplantation | Q42910518 |
| | A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion | Q43752261 |
| | Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice | Q44231164 |
| | Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice. | Q44316900 |
| | Effects of angiotensin II type 1 receptor blockade in ApoE-deficient mice with post-ischemic heart failure | Q44491746 |
| | Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein | Q45018873 |
| | Apolipoprotein E and progression of chronic kidney disease | Q45021112 |
| | Role of apolipoprotein E in renal damage protection | Q45083057 |
| | Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice | Q45119481 |
| | Astrocytes produce and secrete FGF-1, which promotes the production of apoE-HDL in a manner of autocrine action | Q45208064 |
| | Membrane surface charge modulates lipoprotein complex forming capability of peptides derived from the C-terminal domain of apolipoprotein E. | Q46053740 |
| | Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning | Q46163083 |
| | Endothelin-converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins | Q46255902 |
| | Multiple pathways of apolipoprotein E signaling in primary neurons | Q46386555 |
| | Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C. | Q46390049 |
| | Effects of apoE on neuronal signaling and APP processing in rodent brain | Q48448485 |
| | Mechanical injured neurons stimulate astrocytes to express apolipoprotein E through ERK pathway | Q48596971 |
| | High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease | Q49033077 |
| | Detection of apolipoprotein A-I, B, and E immunoreactivity in the nuclei of various rat tissue cells | Q49033501 |
| | Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice. | Q50528684 |
| | Chronic renal failure alters endothelial function in cerebral circulation in mice. | Q51445939 |
| | apoE expression in glomerulus and correlation with glomerulosclerosis induced by adriamycin in rats. | Q53261588 |
| | Apolipoprotein E regulates primary cultured human mesangial cell proliferation. | Q53656289 |
| | Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. | Q53938164 |
| | Long-term follow-up of a paediatric case of lipoprotein glomerulopathy. | Q54328254 |
| | All-trans retinoic acid regulates the expression of apolipoprotein E in rats with glomerulosclerosis induced by Adriamycin. | Q54384110 |
| P433 | issue | 2 | |
| P304 | page(s) | 73-78 | |
| P577 | publication date | 2013-02-06 | |
| P1433 | published in | Journal of Receptors and Signal Transduction | Q6295837 |
| P1476 | title | Signaling pathways of apoE and its role of gene expression in glomerulus diseases | |
| P478 | volume | 33 | |